Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas V Faller

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
The EMBO Journal|June 18, 2002
Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growthSheng Wang, Baohua Zhang, Douglas V Faller
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 28, 2002
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitiveNing Guo, Douglas V Faller, Cyrus Vaziri
The EMBO Journal|May 14, 2004
BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonistsSheng Wang, Baohua Zhang, Douglas V Faller
Molecular Endocrinology (Baltimore, Md.)|October 13, 2009
HIC1 regulates tumor cell responses to endocrine therapiesBaohua Zhang, Douglas V Faller, Sheng Wang
Journal of Cellular Physiology|September 8, 2011
Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cellsAndrew M Rankin, Sibaji Sarkar, Douglas V Faller
The Journal of Biological Chemistry|March 14, 2007
Protein kinase C delta is required for survival of cells expressing activated p21RASShuhua Xia, Lora W Forman, Douglas V Faller
The Biochemical Journal|November 19, 2004
Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin AAnupama Sinha, Douglas V Faller, Gerald V Denis
Journal of Cellular Physiology|November 7, 2003
Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell linesJames S Liou, James S Chen, Douglas V Faller
Advances in Virology|April 14, 2012
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated MalignanciesSajal K Ghosh, Susan P Perrine, Douglas V Faller
Current Cancer Drug Targets|May 29, 2003
Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?James S Chen, Douglas V Faller, Remco A Spanjaard
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
The EMBO Journal|June 18, 2002
Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growthSheng Wang, Baohua Zhang, Douglas V Faller
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 28, 2002
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitiveNing Guo, Douglas V Faller, Cyrus Vaziri
The EMBO Journal|May 14, 2004
BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonistsSheng Wang, Baohua Zhang, Douglas V Faller
Molecular Endocrinology (Baltimore, Md.)|October 13, 2009
HIC1 regulates tumor cell responses to endocrine therapiesBaohua Zhang, Douglas V Faller, Sheng Wang
Journal of Cellular Physiology|September 8, 2011
Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cellsAndrew M Rankin, Sibaji Sarkar, Douglas V Faller
The Journal of Biological Chemistry|March 14, 2007
Protein kinase C delta is required for survival of cells expressing activated p21RASShuhua Xia, Lora W Forman, Douglas V Faller
The Biochemical Journal|November 19, 2004
Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin AAnupama Sinha, Douglas V Faller, Gerald V Denis
Journal of Cellular Physiology|November 7, 2003
Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell linesJames S Liou, James S Chen, Douglas V Faller
Advances in Virology|April 14, 2012
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated MalignanciesSajal K Ghosh, Susan P Perrine, Douglas V Faller
Current Cancer Drug Targets|May 29, 2003
Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?James S Chen, Douglas V Faller, Remco A Spanjaard
Pageof 13